Results 121 to 130 of about 244,822 (281)

A Multicenter Retrospective Study of HbH in China Including 1421 Patients Over a 12‐Year Timespan

eJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Background Hemoglobin H (HbH) disease is a relatively common genetic disorder worldwide. However, the lack of long‐term follow‐up studies involving large patient cohorts has limited our understanding of its clinical features, disease progression, and outcomes.
Hangning Shang, Shijun Xu, Yaqing Zhang, Junbin Liang, Pingping Li, Lihong Zeng, Yufang Gu, Haiying Li, Weiping Wei, Zhen Lu, Zan Chen, Rongying Gong, Xinhua Zhang, Hui Xu, Li Wang   +14 more
wiley   +1 more source

Postoperative shed autologous blood reinfusion does not decrease the need for allogeneic blood transfusion in unilateral and bilateral total knee arthroplasty.

PLoS ONE, 2019
Postoperative shed autologous blood reinfusion techniques have been used for decades in total knee arthroplasty (TKA), but the effectiveness of this procedure is still a matter of debate.
YuLiang Miao, WenZhi Guo, LiNa An, WeiWu Fang, Yan Liu, XiaoPing Wang, LiKun An   +6 more
doaj   +1 more source

Autologous blood transfusion promotes autophagy and inhibits hepatocellular carcinoma progression through HIF-1α signalling pathway. [PDF]

J Cell Mol Med, 2023
Bai Y, Liu T, Cui YH, Li ZZ, Zhou XF, Cheng Y, Wang JH, Guo JR.   +7 more
europepmc   +1 more source

Points: Autologous blood transfusion [PDF]

, 1987
Annette Brown
openalex   +1 more source

A multicenter experience using adipose-derived mesenchymal stem cell therapy for cats with chronic, non-responsive gingivostomatitis. [PDF]

, 2020
BackgroundThe ability of mesenchymal stem cells (MSCs) to modulate immune responses inspired a series of clinical trials addressing oral mucosal inflammation.
Arzi, Boaz, Battig, Jean, Borjesson, Dori L, Clark, Kaitlin C, Delatorre, Ubaldo, Fiani, Nadine, Fulton, Amy, Lommer, Milinda J, Loscar, Megan R, Peralta, Santiago, Taechangam, Nopmanee, Vapniarsky, Natalia, Walker, Naomi J   +12 more
core   +1 more source

Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

Transfusion, EarlyView.
Elizabeth P. Crowe, Jennifer Andrews, Stella T. Chou, Claudia S. Cohn, Mischa L. Covington, Ruchika Goel, Aaron S. Hess, Tina S. Ipe, Jessica Jacobson, Cyril Jacquot, Jenna Khan, Michael F. Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Jacqueline N. Poston, Eric Salazar, Nabiha H. Saifee, Moritz Stolla, Nicole D. Zantek, Alyssa Ziman, Ryan A. Metcalf   +21 more
wiley   +1 more source

Medical and Nutritional Outcomes Are Similar Among Autologous Transplant Patients on Enteral Nutrition When Compared to Parenteral Nutrition. A Randomized Pilot Study

European Journal of Haematology, Volume 115, Issue 2, Page 117-124, August 2025.
ABSTRACT Autologous hematopoietic stem cell transplantation (AHSCT) is the treatment for myeloma and lymphoma. posttreatment, significant nutritional and medical issues and malnutrition assessed by Subjective Global Assessment (SGA) arise. No established effective treatment for using either parenteral (PN) or enteral routes (EN) to improve nutritional ...
Janet Madill, Brenda Hartman, Heather Resvick, Mehraneh Mohebbi, Alison Andrade, Cheryl Sigfrid, Maisam Abouzeeni, Adrienne Fulford, Anargyros Xenocostas, Uday Deotare   +9 more
wiley   +1 more source

Autologous blood transfusion reduces the requirement for perioperative allogenic blood transfusion in patients undergoing major hepatopancreatobiliary surgery: a retrospective cohort study. [PDF]

Int J Surg, 2023
Lakha AS, Chadha R, Von-Kier S, Barbosa A, Maher K, Pirkl M, Stoneham M, Silva MA, Soonawalla Z, Udupa V, Reddy S, Gordon-Weeks A.   +11 more
europepmc   +1 more source

Blood deserts in a universal health system: Addressing structural inequities in northern Canada

Transfusion, EarlyView.
Boaz Laor, Shreenik Kundu
wiley   +1 more source

Healthy volunteer stem cell donors followed up 10 years after stimulation with biosimilar filgrastim

Transfusion, Volume 65, Issue 8, Page 1418-1426, August 2025.
Abstract Background The application of granulocyte colony‐stimulating factors (G‐CSF) for mobilizing hematopoietic stem and progenitor cells in healthy donors is considered safe. However, only limited safety information is available about long‐term adverse events (AEs) in this setting.
Jens Heyn, Susanne Bräuninger, Petra Becker, Niklas Stoeckmann, Christian Seidl, Sebastian Howe, Simon Daubert, Daniel Fürst, Hubert Schrezenmeier, Halvard Bonig   +9 more
wiley   +1 more source